ONM-501 – A polyvalent STING agonist for oncology immunotherapy
Previous
Previous
A polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
Next
Next